https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
https://www.selleckchem.com/pr....oducts/AZD2281(Olapa
Quorum-quenching activity involving some Iranian medical plant life. Post-licensing pharmacometric studies can provide a better understanding of the pharmacokinetic (PK) alterations in special patient populations and may lead to better clinical outcomes. Some patient populations exhibit markedly different pathophysiology to general ward patients or healthy individuals. This may be developmental (paediatric patients), a manifestation of an underlying disease path
Like
Comment
Share
